4//SEC Filing
Mann Brenda 4
Accession 0001104659-20-112300
CIK 0001372514other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 5:56 PM ET
Size
5.3 KB
Accession
0001104659-20-112300
Insider Transaction Report
Form 4
Mann Brenda
VP of Research & Development
Transactions
- Tax Payment
Common Stock
2020-10-02$3.88/sh−98$380→ 17,558 total
Footnotes (2)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 10/01/2020.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.88 to $3.99, inclusive. The reporting person hereby undertakes to provide to EyeGate Pharmaceuticals, Inc., any security holder of EyeGate Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001668858
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 5:56 PM ET
- Size
- 5.3 KB